ALEXANDER'S INC
ALXNYSETrading Snapshot
- Day Range
- $245.77 β $248.87
- 52-Week Range
- $201.28 β $289.43
- Volume
- $3.26B
- Avg Volume
- $3.31B
- Shares Outstanding
- 5.1M
- Next Earnings
- Oct 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $213M
- Last Q Revenue
- $55M
- P/E Ratio
- 7.5
- P/S Ratio
- 5.9x
- EPS (TTM)
- $33.05
- Dividend Yield
- 7.23%
- Dilution (1yr)
- +0.1%
Why Investors Own ALX
- βHigh-growth profile β revenue up +6.7% YoY with expanding US Equity exposure.
- βHealthy economics β 49% gross margin and 9% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
ALEXANDER'S INC
ALXAbout ALEXANDER'S INC
Alexander's, Inc., a real estate investment trust, possesses a portfolio comprising seven properties located across the broader New York City metropolitan region.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Ratings
βLatest News & Updates

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer
Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% versus 23.1% among patients with high CD47 expression and retained HER2-po

Head-To-Head Analysis: Tritax Big Box REIT (OTCMKTS:TTBXF) vs. Alexanderβs (NYSE:ALX)
Alexander's (NYSE: ALX - Get Free Report) and Tritax Big Box REIT (OTCMKTS:TTBXF - Get Free Report) are both real estate companies, but which is the better business? We will contrast the two companies based on the streng

ALX Oncology to Present at Upcoming Investor Conferences in September
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat

Is Alexander's (ALX) Outperforming Other Finance Stocks This Year?
Here is how Alexander's (ALX) and Healthpeak (DOC) have performed compared to their sector so far this year.

Best Momentum Stocks to Buy for August 11th
DINO, QUAD and ALX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 11, 2026.

New Strong Buy Stocks for August 11th
ALX, DINO, OPBK, CYD and HLLY have been added to the Zacks Rank #1 (Strong Buy) List on August 11, 2026.